Scimago Institutions Rankings
menu
| Title | Type |  SJR |
H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 10.106 Q1 | 277 | 202 | 715 | 7107 | 6845 | 321 | 17.06 | 35.18 |  |
| 2 | Pharmacology and Therapeutics | journal | 4.072 Q1 | 175 | 143 | 358 | 25171 | 3782 | 356 | 9.97 | 176.02 | |
| 3 | Natural Product Reports | journal | 3.918 Q1 | 151 | 63 | 253 | 11363 | 2481 | 239 | 10.31 | 180.37 | |
| 4 | Neuropsychopharmacology | journal | 3.327 Q1 | 195 | 278 | 990 | 16323 | 5626 | 916 | 6.13 | 58.72 | |
| 5 | Journal for ImmunoTherapy of Cancer | journal | 2.798 Q1 | 26 | 99 | 219 | 4071 | 1270 | 193 | 6.43 | 41.12 | |
| 6 | Emerging Microbes and Infections | journal | 2.433 Q1 | 27 | 86 | 186 | 2719 | 849 | 148 | 5.56 | 31.62 | |
| 7 | Journal of Antimicrobial Chemotherapy | journal | 2.419 Q1 | 166 | 528 | 1679 | 15487 | 7231 | 1412 | 5.03 | 29.33 | |
| 8 | npj Vaccines | journal | 2.269 Q1 | 4 | 36 | 16 | 1896 | 40 | 15 | 2.67 | 52.67 | |
| 9 | Particle and Fibre Toxicology | journal | 2.253 Q1 | 75 | 52 | 178 | 3214 | 1444 | 172 | 6.26 | 61.81 | |
| 10 | Neuropharmacology | journal | 2.043 Q1 | 146 | 517 | 1232 | 35570 | 5719 | 1212 | 4.27 | 68.80 | |
| 11 | PharmacoEconomics | journal | 1.998 Q1 | 90 | 116 | 327 | 5255 | 1137 | 273 | 4.05 | 45.30 | |
| 12 | Advanced healthcare materials | journal | 1.989 Q1 | 49 | 317 | 834 | 21232 | 4408 | 779 | 5.45 | 66.98 | |
| 13 | Critical Reviews in Toxicology | journal | 1.828 Q1 | 96 | 37 | 121 | 4759 | 698 | 115 | 5.19 | 128.62 | |
| 14 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.816 Q1 | 68 | 23 | 46 | 3288 | 301 | 45 | 6.57 | 142.96 | |
| 15 | International Journal of Neuropsychopharmacology | journal | 1.808 Q1 | 90 | 115 | 548 | 6663 | 2050 | 521 | 3.85 | 57.94 | |
| 16 | Clinical Toxicology | journal | 1.792 Q1 | 81 | 188 | 442 | 3067 | 1472 | 298 | 4.83 | 16.31 | |
| 17 | Nanotoxicology | journal | 1.630 Q1 | 66 | 100 | 366 | 5726 | 2183 | 355 | 5.67 | 57.26 | |
| 18 | Environmental Pollution | journal | 1.615 Q1 | 179 | 1139 | 1918 | 62371 | 9528 | 1881 | 4.47 | 54.76 | |
| 19 | Expert Opinion on Therapeutic Targets | journal | 1.597 Q1 | 74 | 111 | 370 | 10084 | 1532 | 359 | 4.23 | 90.85 | |
| 20 | Expert Review of Vaccines | journal | 1.551 Q1 | 69 | 112 | 419 | 9099 | 1370 | 392 | 3.62 | 81.24 | |
| 21 | British Journal of Clinical Pharmacology | journal | 1.543 Q1 | 126 | 306 | 861 | 11268 | 3021 | 744 | 3.84 | 36.82 | |
| 22 | Toxicological Sciences | journal | 1.538 Q1 | 159 | 238 | 797 | 11998 | 3311 | 729 | 4.39 | 50.41 | |
| 23 | Therapeutic Advances in Neurological Disorders | journal | 1.522 Q1 | 35 | 34 | 103 | 1851 | 456 | 96 | 5.11 | 54.44 | |
| 24 | Human Genomics | journal | 1.501 Q1 | 43 | 29 | 91 | 904 | 307 | 82 | 3.87 | 31.17 | |
| 25 | Clinical Pharmacokinetics | journal | 1.482 Q1 | 146 | 166 | 313 | 7053 | 1316 | 276 | 4.42 | 42.49 | |
| 26 | Drug Safety | journal | 1.447 Q1 | 112 | 120 | 324 | 4822 | 1078 | 267 | 3.86 | 40.18 | |
| 27 | Expert Opinion on Drug Delivery | journal | 1.432 Q1 | 81 | 122 | 431 | 10421 | 2115 | 410 | 5.12 | 85.42 | |
| 28 | Journal of Nanobiotechnology | journal | 1.380 Q1 | 51 | 92 | 235 | 5120 | 1281 | 230 | 5.23 | 55.65 | |
| 29 | Alcohol and Alcoholism | journal | 1.376 Q1 | 88 | 112 | 323 | 3389 | 818 | 293 | 2.17 | 30.26 | |
| 30 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.346 Q1 | 78 | 87 | 258 | 2945 | 708 | 242 | 2.79 | 33.85 | |
| 31 | Pharmacogenomics Journal | journal | 1.320 Q1 | 75 | 98 | 231 | 3725 | 809 | 228 | 3.42 | 38.01 | |
| 32 | Expert Opinion on Drug Discovery | journal | 1.309 Q1 | 46 | 107 | 311 | 10793 | 1107 | 295 | 4.32 | 100.87 | |
| 33 | Addictive Behaviors | journal | 1.290 Q1 | 108 | 339 | 888 | 13440 | 2692 | 878 | 2.65 | 39.65 | |
| 34 | Drugs in Context | journal | 1.194 Q1 | 10 | 11 | 39 | 359 | 121 | 37 | 3.07 | 32.64 | |
| 35 | Statistics in Biopharmaceutical Research | journal | 1.187 Q1 | 8 | 44 | 114 | 925 | 85 | 100 | 0.81 | 21.02 | |
| 36 | Expert Opinion on Investigational Drugs | journal | 1.166 Q1 | 92 | 140 | 406 | 10495 | 1300 | 388 | 3.55 | 74.96 | |
| 37 | Expert Opinion on Biological Therapy | journal | 1.117 Q1 | 73 | 151 | 488 | 12513 | 1485 | 461 | 3.60 | 82.87 | |
| 38 | Future Medicinal Chemistry | journal | 1.111 Q1 | 49 | 160 | 534 | 10039 | 1496 | 440 | 3.35 | 62.74 | |
| 39 | Expert Opinion on Emerging Drugs | journal | 1.109 Q2 | 43 | 28 | 130 | 3050 | 360 | 121 | 3.35 | 108.93 | |
| 40 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 1.040 Q1 | 60 | 141 | 594 | 6429 | 1980 | 591 | 3.52 | 45.60 | |
| 41 | BioDrugs | journal | 1.038 Q2 | 57 | 47 | 139 | 3085 | 461 | 127 | 4.08 | 65.64 | |
| 42 | Pharmacology Research and Perspectives | journal | 1.005 Q1 | 14 | 83 | 233 | 3468 | 619 | 229 | 2.79 | 41.78 | |
| 43 | Antiviral Therapy | journal | 0.958 Q2 | 77 | 92 | 312 | 2597 | 591 | 299 | 1.87 | 28.23 | |
| 44 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.954 Q2 | 68 | 121 | 421 | 10053 | 1272 | 400 | 3.12 | 83.08 | |
| 45 | Expert Opinion on Therapeutic Patents | journal | 0.926 Q2 | 59 | 105 | 329 | 8792 | 942 | 323 | 2.66 | 83.73 | |
| 46 | F1000Research | journal | 0.926 Q1 | 21 | 722 | 1327 | 37514 | 2078 | 1240 | 1.71 | 51.96 | |
| 47 | Molecular Diagnosis and Therapy | journal | 0.923 Q2 | 33 | 67 | 188 | 4237 | 452 | 181 | 2.70 | 63.24 | |
| 48 | Mutagenesis | journal | 0.916 Q2 | 81 | 56 | 222 | 2010 | 573 | 218 | 2.67 | 35.89 | |
| 49 | Expert Opinion on Pharmacotherapy | journal | 0.909 Q2 | 67 | 208 | 754 | 13884 | 2029 | 710 | 3.04 | 66.75 | |
| 50 | Journal of Toxicology and Environmental Health - Part A | journal | 0.888 Q2 | 76 | 123 | 362 | 6172 | 967 | 357 | 2.73 | 50.18 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2018. Data Source: Scopus®
Download data